Back to search

Article

M 6A-related genes characterization in hepatocellular cancer identifies prognostic relevant gene signatures

2020-02-04

Abstract excerpt

<title>Abstract</title> <p>Background Hepatocellular carcinoma (HCC) is among the most common types of cancers that threat the public health worldwide. N6-methyladenosine (m6A) RNA methylation, associated with cancer initiation and progression, is dynamically regulated by m6A RNA methylation associated genes. However, little is known about the expression status and the prognostic value of m6A associated genes in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b035d741-58f5-54bb-bbe8-b92307b6c1fe
DOI
10.21203/rs.2.22602/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
M 6A-related genes characterization in hepatocellular cancer identifies prognostic relevant gene signaturesDOI 10.21203/rs.2.22602/v1
Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity
The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinomaSemantic proximity
RNA m6A methylation regulator-mediated modification patterns and tumor microenvironment characterization in hepatocellular carcinomaSemantic proximity
M6a Regulator-Associated Methylation Modification Patterns Shape Tumor Microenvironment Characteristics in Hepatocellular CarcinomaSemantic proximity
Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment ResponseSemantic proximity
The m6A Methylation Gene SNRPC can be used as a Biomarker for the Prognosis and Immunotherapy of Hepatocellular CarcinomaSemantic proximity
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of esophageal adenocarcinomaSemantic proximity
Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancerSemantic proximity
m6A RNA Methylation Regulators de fine tumor microenvironment and predict prognosis in hepatocellular carcinomaSemantic proximity
Integrated Analysis of Methylation-driven Genes and Pretreatment Prognostic Factors in Patients with Hepatocellular CarcinomaSemantic proximity
A novel signature based on m6A related genes as the potential prognostic factor in hepatocellular carcinoma.Semantic proximity
The Significance of Prognostic m6A RNA Methylation Regulators in Tumor Immune Environment and Immune Therapy of Hepatocellular CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.